tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Ondine Biomedical Advances ICU Infection Prevention with New Share Issuance

Story Highlights
Ondine Biomedical Advances ICU Infection Prevention with New Share Issuance

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Ondine Biomedical, Inc. ( (GB:OBI) ) has shared an announcement.

Ondine Biomedical Inc. announced the issuance of 800,457 common shares to the Royal Columbian Hospital Foundation following the completion of patient enrollment in a groundbreaking ICU nasal photodisinfection trial using Steriwave. This share issuance marks a significant milestone in the trial, which aims to explore the feasibility of Steriwave as a nasal decolonization tool in intensive care settings, potentially impacting the company’s market position in the ICU infection prevention sector.

The most recent analyst rating on (GB:OBI) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Ondine Biomedical, Inc. stock, see the GB:OBI Stock Forecast page.

More about Ondine Biomedical, Inc.

Ondine Biomedical Inc. is a Canadian life sciences company specializing in light-activated antimicrobial therapies, known as photodisinfection, for infection prevention and treatment. The company has a range of investigational products based on its proprietary technology, with approvals in several countries and ongoing trials for regulatory approval in the US.

Average Trading Volume: 166,062

Technical Sentiment Signal: Buy

Current Market Cap: £57.62M

For detailed information about OBI stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1